AI assistant
EXACT SCIENCES CORP — Director's Dealing 2014
Oct 20, 2014
30597_dirs_2014-10-20_ed606e13-fbd4-4202-8b1c-d50db6228d9f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2014-10-16
Reporting Person: CRAWFORD SALLY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-16 | Common Stock | M | 5000 | $2.24 | Acquired | 217341 | Direct |
| 2014-10-16 | Common Stock | M | 15000 | $2.09 | Acquired | 232341 | Direct |
| 2014-10-16 | Common Stock | M | 7768 | $3.00 | Acquired | 240109 | Direct |
| 2014-10-16 | Common Stock | S | 27768 | $22.8418 | Disposed | 212341 | Direct |
| 2014-10-17 | Common Stock | M | 7232 | $3.00 | Acquired | 219573 | Direct |
| 2014-10-17 | Common Stock | M | 15000 | $0.71 | Acquired | 234573 | Direct |
| 2014-10-17 | Common Stock | M | 5536 | $3.43 | Acquired | 240109 | Direct |
| 2014-10-17 | Common Stock | S | 27768 | $23.6823 | Disposed | 212341 | Direct |
| 2014-10-20 | Common Stock | M | 2131 | $3.43 | Acquired | 214472 | Direct |
| 2014-10-20 | Common Stock | M | 15772 | $8.52 | Acquired | 230244 | Direct |
| 2014-10-20 | Common Stock | M | 5257 | $8.52 | Acquired | 235501 | Direct |
| 2014-10-20 | Common Stock | M | 4608 | $10.18 | Acquired | 240109 | Direct |
| 2014-10-20 | Common Stock | S | 27768 | $23.9323 | Disposed | 212341 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-16 | Stock Option (right to buy) | $2.24 | M | 5000 | Disposed | 2015-07-22 | Common Stock (15000) | Direct |
| 2014-10-16 | Stock Option (right to buy) | $2.09 | M | 15000 | Disposed | 2016-07-21 | Common Stock (15000) | Direct |
| 2014-10-16 | Stock Option (right to buy) | $3.00 | M | 7768 | Disposed | 2017-08-10 | Common Stock (15000) | Direct |
| 2014-10-17 | Stock Option (right to buy) | $3.00 | M | 7232 | Disposed | 2017-08-10 | Common Stock (7232) | Direct |
| 2014-10-17 | Stock Option (right to buy) | $0.71 | M | 15000 | Disposed | 2018-07-18 | Common Stock (15000) | Direct |
| 2014-10-17 | Stock Option (right to buy) | $3.43 | M | 5536 | Disposed | 2020-07-16 | Common Stock (7667) | Direct |
| 2014-10-20 | Stock Option (right to buy | $3.43 | M | 2131 | Disposed | 2020-07-16 | Common Stock (2131) | Direct |
| 2014-10-20 | Stock Option (right to buy) | $8.52 | M | 15772 | Disposed | 2021-07-28 | Common Stock (15772) | Direct |
| 2014-10-20 | Stock Option (right to buy) | $8.52 | M | 5257 | Disposed | 2021-07-28 | Common Stock (5257) | Direct |
| 2014-10-20 | Stock Option (right to buy) | $10.18 | M | 4608 | Disposed | 2022-07-26 | Common Stock (4608) | Direct |
Footnotes
F1: The exercise of these options and the subsequent sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted September 8, 2014. The sales of shares pursuant to this 10b5-1 trading plan and disclosed on this Form 4 reflect the execution of all shares subject to the 10b5-1 trading plan. As a result, the 10b5-1 trading plan has been terminated effective as of the filing of this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.65 to $23.11, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.50 to $24.02, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.72 to $24.05, inclusive. The reporting person undertakes to provide Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.